# Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

Study · id `cardio:ct-nct06571149` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06571149](<https://clinicaltrials.gov/study/NCT06571149>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06571149

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 906 participants.

## Technical summary

Registry record NCT06571149. Randomized; no masking; primary purpose treatment. Start 2025-03-14 (actual); primary completion 2029-01-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 906 participants (planned count; ClinicalTrials.gov record NCT06571149, source copy `cardio:ctgov-nct06571149-2026-09-30`, retrieved 2026-10-26)
- Started: 2025-03-14 (actual) (ClinicalTrials.gov record NCT06571149, source copy `cardio:ctgov-nct06571149-2026-09-30`, retrieved 2026-10-26)
- Primary completion: 2029-01-31 (anticipated) (ClinicalTrials.gov record NCT06571149, source copy `cardio:ctgov-nct06571149-2026-09-30`, retrieved 2026-10-26)
- Completion: 2029-04-30 (anticipated) (ClinicalTrials.gov record NCT06571149, source copy `cardio:ctgov-nct06571149-2026-09-30`, retrieved 2026-10-26)
- Countries: Austria; Belgium; Canada; Finland; France; Germany; Greece; Netherlands; Norway; Portugal; Spain; Switzerland (ClinicalTrials.gov record NCT06571149, source copy `cardio:ctgov-nct06571149-2026-09-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06571149-2026-09-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
- Acronym: DO-IT
- Condition: Ischemic Stroke
- Intervention (Drug): Tenecteplase or Alteplase
- Lead sponsor: Insel Gruppe AG, University Hospital Bern
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Insel Gruppe AG, University Hospital Bern (`cardio:org-insel-gruppe-ag-university-hospital-bern`)

## Provenance

Content hash: b999bfc8fc380488aab4b0092ff9f2a68e08c4eb64ce8d2c7aa985d316fcbd72
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
